Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

REGN.US Logo

REGN.US - Current Price

$748.13

Company Information

▼
Company Name
Regeneron Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US75886F1075
CIK: 0000872589
CUSIP: 75886F107
Currency: USD
Full Time Employees: 15,222
Phone: 914 847 7000
Website: https://www.regeneron.com
Fiscal Year End: December
IPO Date: Apr 02, 1991
Description:

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia (HoFH) or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; Evkeeza for treatment of HoFH; Ordspono for Follicular lymphoma and Diffuse large B-cell lymphoma; and Veopoz for CD55-deficient protein-losing enteropathy. Further, it develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types; with Sonoma Biotherapeutics, Inc. to discover, develop, and commercialize engineered regulatory T cell therapies; and Tessera Therapeutics, Inc. to develop and commercialize TSRA-196, an investigational gene editing therapy for Alpha-1 antitrypsin deficiency. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

Address:

777 Old Saw Mill River Road, Tarrytown, NY, United States, 10591-6707

Directors & Officers

▼
Name Title Year Born
Dr. Leonard S. Schleifer M.D., Ph.D. Co-Founder, President, CEO & Co-Chairman 1953
Dr. George D. Yancopoulos M.D., Ph.D. Co-Founder, President, Chief Scientific Officer & Co-Chairman 1960
Mr. Christopher R. Fenimore CPA Executive VP of Finance & CFO 1971
Dr. Andrew J. Murphy Ph.D. Executive VP of Research & Co-Chief Scientific Officer 1958
Mr. Daniel P. Van Plew Executive VP and GM of Industrial Operations & Product Supply 1973
Mr. Rajesh Ahuja Senior Vice President of Quality Assurance & Operations NA
Mr. Bob McCowan Senior VP of IT & Chief Information Officer NA
Mr. Ryan Crowe Senior Vice President of Investor Relations & Strategic Analysis NA
Mr. Joseph J. LaRosa J.D. Executive VP, General Counsel & Secretary 1959
Ms. Melissa Lozner Senior VP & Chief Compliance Officer NA

Shares Statistics

▼
Shares Outstanding: 103.28M
Shares Float: 98.52M
% Insiders: 202.70%
% Institutions: 9,037.00%
Short % Float: 2.50%

Valuation Metrics

▼
Enterprise Value: $74.98B
Trailing P/E: 18.42
Forward P/E: 17.45

Financial Highlights

▼
Market Cap: $81.40B
EBITDA: $4.35B
P/E Ratio: $18.42
PEG Ratio: $1.46
Book Value: $301.15
Dividend/Share: $2.64
Dividend Yield: 0.33%
Earnings/Share: $41.70
Profit Margin: 32.13%
Operating Margin: 29.56%
ROA (TTM): 6.16%
ROE (TTM): 15.19%
Revenue (TTM): $14.25B
Revenue/Share (TTM): $134.76
Earnings Growth (YOY): 18.00%
Revenue Growth (YOY): 0.90%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Dec 31, 2025 0.00 10.77 N/A -10,000.00%
Sep 30, 2025 11.83 9.67 N/A 2,233.71%
Jun 30, 2025 12.89 8.44 N/A 5,272.51%
Mar 31, 2025 8.22 8.48 N/A -306.60%
Dec 31, 2024 12.07 11.19 N/A 786.42%
Sep 30, 2024 12.46 11.70 N/A 649.57%
Jun 30, 2024 11.56 10.61 N/A 895.38%
Mar 31, 2024 9.55 10.09 N/A -535.18%
Dec 31, 2023 11.86 10.73 N/A 1,053.12%
Sep 30, 2023 11.59 10.72 N/A 811.57%
Jun 30, 2023 10.24 9.84 N/A 406.50%
Mar 31, 2023 10.09 9.56 N/A 554.39%
Dec 31, 2022 12.56 10.03 N/A 2,522.43%
Sep 30, 2022 11.14 9.48 N/A 1,751.05%
Jun 30, 2022 9.77 8.84 N/A 1,052.04%
Mar 31, 2022 8.93 9.74 N/A -831.62%
Dec 31, 2021 21.32 18.35 N/A 1,618.53%
Sep 30, 2021 14.37 10.10 N/A 4,227.72%
Jun 30, 2021 25.80 17.53 N/A 4,717.63%
Mar 31, 2021 9.89 9.00 N/A 988.89%
Dec 31, 2020 9.53 8.39 N/A 1,358.76%
Sep 30, 2020 8.36 7.14 N/A 1,708.68%
Jun 30, 2020 7.16 5.98 N/A 1,973.24%
Mar 31, 2020 6.60 6.13 N/A 766.72%
Dec 31, 2019 7.50 6.91 N/A 853.84%
Sep 30, 2019 6.67 6.36 N/A 487.42%
Jun 30, 2019 6.02 5.41 N/A 1,127.54%
Mar 31, 2019 4.45 5.47 N/A -1,864.72%
Dec 31, 2018 6.84 5.60 N/A 2,214.29%
Sep 30, 2018 5.87 5.13 N/A 1,442.50%
Jun 30, 2018 5.45 4.70 N/A 1,595.74%
Mar 31, 2018 4.67 4.35 N/A 735.63%
Dec 31, 2017 5.23 4.53 N/A 1,545.25%
Sep 30, 2017 3.99 3.85 N/A 363.64%
Jun 30, 2017 4.17 3.17 N/A 3,154.57%
Mar 31, 2017 2.92 3.06 N/A -457.52%
Dec 31, 2016 3.04 3.03 N/A 33.00%
Sep 30, 2016 3.13 2.71 N/A 1,549.82%
Jun 30, 2016 2.82 2.65 N/A 641.51%
Mar 31, 2016 2.57 2.58 N/A -38.76%
Dec 31, 2015 2.83 3.36 N/A -1,577.38%
Sep 30, 2015 3.47 3.20 N/A 843.75%
Jun 30, 2015 2.89 2.77 N/A 433.21%
Mar 31, 2015 2.88 2.68 N/A 746.27%
Dec 31, 2014 2.79 2.82 N/A -106.38%
Sep 30, 2014 2.52 2.57 N/A -194.55%
Jun 30, 2014 2.47 2.29 N/A 786.03%
Mar 31, 2014 2.26 2.20 N/A 272.73%
Dec 31, 2013 0.86 0.98 N/A -1,224.49%
Sep 30, 2013 1.25 0.90 N/A 3,888.89%
Jun 30, 2013 0.79 0.88 N/A -1,022.73%
Mar 31, 2013 0.90 0.98 N/A -816.33%
Dec 31, 2012 1.22 1.10 N/A 1,090.91%
Sep 30, 2012 1.72 0.95 N/A 8,105.26%
Jun 30, 2012 0.70 0.27 N/A 15,925.93%
Mar 31, 2012 0.16 -0.23 N/A 16,956.52%
Dec 31, 2011 -0.54 -0.60 N/A 1,000.00%
Sep 30, 2011 -0.68 -0.76 N/A 1,052.63%
Jun 30, 2011 -0.69 -0.41 N/A -6,829.27%
Mar 31, 2011 -0.49 -0.36 N/A -3,611.11%
Dec 31, 2010 -0.17 -0.32 N/A 4,687.50%
Sep 30, 2010 -0.41 -0.34 N/A -2,058.82%
Jun 30, 2010 -0.31 -0.37 N/A 1,621.62%
Mar 31, 2010 -0.38 -0.49 N/A 2,244.90%
Dec 31, 2009 -0.46 -0.34 N/A -3,529.41%
Sep 30, 2009 -0.01 -0.21 N/A 9,523.81%
Jun 30, 2009 -0.19 -0.28 N/A 3,214.29%
Mar 31, 2009 -0.22 -0.31 N/A 2,903.23%
Dec 31, 2008 -0.40 -0.30 N/A -3,333.33%
Sep 30, 2008 -0.27 -0.32 N/A 1,562.50%
Jun 30, 2008 -0.23 -0.30 N/A 2,333.33%
Mar 31, 2008 -0.15 -0.32 N/A 5,312.50%
Dec 31, 2007 -0.19 -0.47 N/A 5,957.45%
Sep 30, 2007 -0.54 -0.30 N/A -8,000.00%
Jun 30, 2007 -0.41 -0.43 N/A 465.12%
Mar 31, 2007 -0.46 -0.50 N/A 800.00%
Dec 31, 2006 -0.51 -0.51 N/A 0.00%
Sep 30, 2006 -0.48 -0.56 N/A 1,428.57%
Jun 30, 2006 -0.41 -0.56 N/A 2,678.57%
Mar 31, 2006 -0.36 -0.61 N/A 4,098.36%
Dec 31, 2005 -0.53 -0.65 N/A 1,846.15%
Sep 30, 2005 -0.52 -0.59 N/A 1,186.44%
Jun 30, 2005 -0.38 -0.51 N/A 2,549.02%
Mar 31, 2005 -0.07 -0.28 N/A 7,500.00%
Dec 31, 2004 0.05 -0.36 N/A 11,388.89%
Sep 30, 2004 -0.20 -0.40 N/A 5,000.00%
Jun 30, 2004 -0.26 -0.30 N/A 1,333.33%
Mar 31, 2004 1.06 -0.46 N/A 33,043.48%
Dec 31, 2003 -0.35 -0.53 N/A 3,396.23%
Sep 30, 2003 -0.52 -0.54 N/A 370.37%
Jun 30, 2003 -0.58 -0.60 N/A 333.33%
Mar 31, 2003 -0.68 -0.85 N/A 2,000.00%
Dec 31, 2002 -0.81 -0.85 N/A 470.59%
Sep 30, 2002 -0.75 -0.78 N/A 384.62%
Jun 30, 2002 -0.69 -0.64 N/A -781.25%
Mar 31, 2002 -0.58 -0.62 N/A 645.16%
Dec 31, 2001 -0.65 -0.62 N/A -483.87%
Sep 30, 2001 -0.46 -0.55 N/A 1,636.36%
Jun 30, 2001 -0.34 -0.52 N/A 3,461.54%
Mar 31, 2001 -0.35 -0.43 N/A 1,860.47%
Dec 31, 2000 -0.23 -0.34 N/A 3,235.29%
Sep 30, 2000 -0.09 -0.30 N/A 7,000.00%
Jun 30, 2000 -0.08 -0.13 N/A 3,846.15%
Mar 31, 2000 -0.23 -0.12 N/A -9,166.67%
Dec 31, 1999 -0.04 -0.21 N/A 8,095.24%
Sep 30, 1999 -0.16 -0.20 N/A 2,000.00%
Jun 30, 1999 -0.25 -0.25 N/A 0.00%
Mar 31, 1999 -0.29 N/A N/A N/A
Dec 31, 1998 -0.18 N/A N/A N/A
Sep 30, 1998 -0.05 N/A N/A N/A
Jun 30, 1998 0.07 N/A N/A N/A
Mar 31, 1998 -0.12 N/A N/A N/A
Jun 30, 1997 -0.16 -0.21 N/A 2,380.95%
Mar 31, 1997 -0.23 -0.38 N/A 3,947.37%
Dec 31, 1996 -0.32 -0.33 N/A 303.03%
Sep 30, 1996 -0.35 -0.34 N/A -294.12%
Jun 30, 1996 -0.31 -0.40 N/A 2,250.00%
Mar 31, 1996 -0.35 -0.36 N/A 277.78%
Dec 31, 1995 -0.38 -0.30 N/A -2,666.67%
Sep 30, 1995 -0.32 -0.39 N/A 1,794.87%
Jun 30, 1995 -0.22 -0.24 N/A 833.33%
Mar 31, 1995 -0.22 -0.35 N/A 3,714.29%
Dec 31, 1994 -0.30 -0.39 N/A 2,307.69%
Sep 30, 1994 -0.21 -0.36 N/A 4,166.67%
Jun 30, 1994 -0.54 -0.58 N/A 689.66%

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $2.49B $N/A $37.76B $8.41B $29.35B
2023-12-31 $2.73B $N/A $33.08B $7.11B $25.97B
2022-12-31 $3.11B $N/A $29.21B $6.55B $22.66B
2021-12-31 $2.89B $N/A $25.43B $6.67B $18.77B
2020-12-31 $2.19B $N/A $17.16B $6.14B $11.03B
2019-12-31 $1.62B $N/A $14.81B $3.72B $11.09B
2018-12-31 $1.47B $N/A $11.73B $2.98B $8.76B
2017-12-31 $812.73M $N/A $8.76B $2.62B $6.14B
2016-12-31 $535.20M $N/A $6.97B $2.52B $4.45B
2015-12-31 $809.10M $N/A $5.61B $1.95B $3.65B
2014-12-31 $648.72M $N/A $3.87B $1.33B $2.54B
2013-12-31 $535.61M $N/A $2.95B $998.94M $1.95B
2012-12-31 $230.28M $N/A $2.08B $835.11M $1.25B
2011-12-31 $483.61M $N/A $1.32B $837.85M $485.73M
2010-12-31 $112.57M $N/A $1.09B $561.62M $527.82M
2009-12-31 $207.08M $N/A $741.20M $344.44M $396.76M
2008-12-31 $247.80M $N/A $670.04M $251.19M $418.85M
2007-12-31 $498.93M $N/A $936.26M $475.99M $460.27M
2006-12-31 $237.88M $N/A $585.09M $368.47M $216.62M
2005-12-31 $184.51M $N/A $423.50M $309.50M $114.00M
2004-12-31 $101.23M $N/A $473.11M $290.57M $182.54M
2003-12-31 $118.29M $N/A $479.56M $341.91M $137.64M
2002-12-31 $80.08M $N/A $391.57M $245.59M $145.98M
2001-12-31 $247.39M $N/A $495.40M $229.04M $266.36M
2000-12-31 $30.98M $N/A $208.27M $26.14M $182.13M
1999-12-31 $23.70M $N/A $137.00M $27.50M $109.50M
1998-12-31 $19.80M $N/A $156.90M $25.70M $131.20M
1997-12-31 $28.90M $N/A $168.40M $29.50M $138.90M
1996-12-31 $34.50M $N/A $137.60M $30.70M $106.90M
1995-12-31 $32.70M $N/A $93.80M $25.90M $67.90M
1994-12-31 $23.60M $N/A $94.20M $27.10M $67.10M
1993-12-31 $12.50M $N/A $117.60M $19.20M $98.40M
1992-12-31 $16.40M $N/A $97.90M $10.70M $87.20M
1991-12-31 $26.20M $N/A $114.00M $7.80M $106.20M
1990-12-31 $21.80M $N/A $25.40M $13.20M $12.20M

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Sep 29, 2025 N/A N/A N/A N/A N/A N/A
Aug 26, 2025 N/A N/A N/A N/A N/A N/A
Aug 04, 2025 N/A N/A N/A N/A N/A N/A
Jul 25, 2025 N/A N/A N/A N/A N/A N/A
Jul 01, 2025 N/A N/A N/A N/A N/A N/A
May 28, 2025 N/A N/A N/A N/A N/A N/A
May 19, 2025 N/A N/A N/A N/A N/A N/A
May 15, 2025 N/A N/A N/A N/A N/A N/A
Apr 15, 2025 N/A N/A N/A N/A N/A N/A
Apr 10, 2025 N/A N/A N/A N/A N/A N/A
Apr 09, 2025 N/A N/A N/A N/A N/A N/A
Apr 08, 2025 N/A N/A N/A N/A N/A N/A
Apr 07, 2025 N/A N/A N/A N/A N/A N/A
Apr 01, 2025 N/A N/A N/A N/A N/A N/A
Feb 25, 2025 N/A N/A N/A N/A N/A N/A
Feb 12, 2025 N/A N/A N/A N/A N/A N/A
Jan 24, 2025 N/A N/A N/A N/A N/A N/A
Jan 15, 2025 N/A N/A N/A N/A N/A N/A
Nov 29, 2024 N/A N/A N/A N/A N/A N/A
Nov 19, 2024 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist